afatinib
SpainDrugs containing this active substance
-
It is used to treat adult patients with a specific type of non-small cell lung cancer that has a mutation in the EGFR gene, either as a first-line treatment or if previous chemotherapy has not worked. It is also used in squamous cell carcinoma if previous chemotherapy has been insufficient.
Form: tablets, film-coated
Active substance Dosage afatinib 20 mg Manufacturer: Boehringer Ingelheim International Gmbh
-
It is used to treat a specific type of non-small cell lung cancer in adults that presents a mutation in the EGFR gene, either as a first-line treatment or when chemotherapy has not worked. It is also used in squamous cell cases if previous chemotherapy has been insufficient.
Form: tablets, film-coated
Active substance Dosage afatinib 30 mg Manufacturer: Boehringer Ingelheim International Gmbh
-
It is used to treat adult patients with a specific type of non-small cell lung cancer that has a mutation in the EGFR gene. It can be prescribed as a first-line treatment or when chemotherapy has not worked.
Form: tablets, film-coated
Active substance Dosage afatinib 40 mg Manufacturer: Boehringer Ingelheim International Gmbh